Glen Harbor Capital Management’s NovoCure NVCR Stock Holding History

Glen Harbor Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-8,112	Closed	-$177K	–	1286
2018 Q1	$177K	Hold	8,112	–	–	﹤0.01%	1012
2017 Q4	$164K	Hold	8,112	–	–	﹤0.01%	1045
2017 Q3	$161K	Hold	8,112	–	–	﹤0.01%	983
2017 Q2	$140K	Hold	8,112	–	–	﹤0.01%	976
2017 Q1	$66K	Hold	8,112	–	–	﹤0.01%	1065
2016 Q4	$64K	Buy	+8,112	New	+$65.2K	﹤0.01%	1032

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Glen Harbor Capital Management's NVCR Position: Q2 2018 in Review

Glen Harbor Capital Management sold out of NovoCure (NVCR) in Q2 2018, closing a stake of 8,112 shares — an estimated $177K sold.

Glen Harbor Capital Management first reported a position in NVCR in Q4 2016 and held it in 6 quarters. The position peaked at $177K in Q1 2018. 161 funds tracked by Wall St. Rank hold NVCR as of Q2 2018.

Glen Harbor Capital Management reported no remaining NovoCure position as of Q2 2018 after selling out during the quarter.
Glen Harbor Capital Management sold 8,112 NovoCure shares in Q2 2018, an estimated $177K.
Glen Harbor Capital Management first reported a position in NovoCure in Q4 2016 and held it in 6 quarters.
Glen Harbor Capital Management's NovoCure position peaked at $177K in Q1 2018.
161 funds tracked by Wall St. Rank held NovoCure as of Q2 2018.

Based on Glen Harbor Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.